Since the first reports of neurofeedback treatment in ADHD in 1976 many studies have been carried out investigating the effects of neurofeedback on different symptoms of ADHD such as inattention, impulsivity and hyperactivity. This technique is also used by many practitioners, but the question as to the evidence-based level of this treatment is still unclear.
In this study selected research on neurofeedback treatment for ADHD was collected and a meta-analysis was performed. Both prospective controlled studies and studies employing a pre- and post-design found large effect sizes (ES) for neurofeedback on impulsivity and inattention and a medium ES for hyperactivity. Randomised studies demonstrated a lower ES for hyperactivity suggesting that hyperactivity is probably most sensitive to non-specific treatment factors.
Due to the inclusion of some very recent and sound methodological studies in this meta-analysis potential confounding factors such as small studies, lack of randomisation in previous studies and a lack of adequate control groups have been addressed and the clinical effects of neurofeedback in the treatment of ADHD can be regarded as clinically meaningful.
Three randomised studies have employed a semi-active control group, which can be regarded as a credible sham control providing an equal level of cognitive training and client-therapist interaction. Therefore, in line with the AAPB and ISNR guidelines for rating clinical efficacy, we conclude that neurofeedback treatment for ADHD can be considered ‘Efficacious and Specific’ (Level 5) with a large ES for inattention and impulsivity and a medium ES for hyperactivity.
Dr Rowe’s presentation discusses the use of scientific theory in driving clinical assessment and treatment through the use of individual patient neurophysiological, neuropsychological and psychological
Quantitative EEG is a direct measure of the electrical energies of the brain which are produced by synapses on the dendrites and cell bodies of cortical pyramidal cells. The network dynamics necessary for proper function of the brain can be disrupted following a traumatic brain injury and can persist for years following even apparently minor injuries with no associated loss of consciousness.
The QEEG data collected in STARTTS Neurofeedback clinic indicates that the excessive temporal lobe alpha and frontal lobe disturbances are two profiles seen most frequently in traumatized clients.
In the 1990s Prof. Yuri Kropotov started his research in the field of quantitative EEG and evoked potentials in normal subjects, in ADHD population and in neurological patients to whom intracranial electrodes were implanted for diagnosis and therapy.
An important task of the human central nervous system is to link sensory information to appropriate response. This is the defining characteristic of adaptive behaviour in humans. Such adaptability is presumed to be mediated by working memory systems that process and respond to detected stimuli according to experience, needs, context and intention, and underpin the capacity to realise goals and plans.
This presentation will review the research of Dr. Robert Coben with Autistic Children with a view to understanding his coherence training methodology. Dr. Gary Schummer has analysed and adapted this methodology in his own research with ADHD and Autistic Spectrum children. Drs. Coben and Schummer base their coherence training on the Neuro Rep analysis of Dr. William Hudspeth.
This presentation, "Responding to the needs of consumers with complex trauma histories a consumer perspective" focuses on the needs of adult survivors of child abuse, highlighting the frequent